Skip to main content
EverLife Lab

Human research · Evidence checked 26 October 2026

What biological-age studies actually found

Published clock measurements can help explain the research. Each number below belongs to a particular study, population and comparison. It does not predict your response or how long you will live.

Randomized trial · Post hoc biomarker analysis

DO-HEALTH

2.9–3.8 months

Less biological aging on selected clocks over 3 years, compared with no omega-3 treatment.

Who was studied
777 Swiss adults aged 70 or older, within the larger randomized trial.
What changed
Omega-3 was associated with slower change on selected DNA-methylation clocks. The combined interventions had an additive effect on PhenoAge.
Limits
Results varied by clock. This was a post hoc analysis of a relatively healthy subgroup, with two measurement time points. A longer lifespan was not established.
Read the Nature Aging paper (2025) (opens in a new tab)

Exploratory pilot · No randomized comparison group

Original TRIIM pilot

About 1.5 years

Lower mean epigenetic age than baseline after 12 months of treatment.

Who was studied
9 analyzed male volunteers from a group aged 51–65.
What changed
The investigators reported an average decline across four epigenetic clocks.
Limits
The small, uncontrolled pilot needs replication. Its findings do not establish longer survival and must not be assigned to the later TRIIM-X extension.
Read the Aging Cell paper (2019) (opens in a new tab)

How to read an age-clock result

A biological-age clock estimates an aspect of aging from biomarkers. A change in that estimate is not a change in chronological age, proof of whole-body rejuvenation, or a measured gain in lifespan. Results from different clocks and study designs are not directly interchangeable.

EverLife shows these as published research findings, not personal treatment estimates. An ongoing trial does not inherit the result of an earlier study. Where a reliable result has not been established, we do not assign a number. Discuss investigational treatment risks with a qualified clinician.

Explore therapy researchBrowse the trial catalog